Not applicableWithdrawnNCT03935308What this trial is testingPhase I Study MR-guided SBRT to PCaWho this might be right forLow or Intermediate Risk Prostate Cancer Henry Ford Health System
Not applicableNot Yet RecruitingNCT07130682What this trial is testingTwo-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II TrialWho this might be right forProstate Cancer Patients Treated by Radiotherapy Hong Kong Sanatorium & Hospital 35
Early research (Phase 1)Ended earlyNCT02875223What this trial is testingA Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's LymphomasWho this might be right forLymphoma, Non-HodgkinNeoplasms Celgene 75
Testing effectiveness (Phase 2)Looking for participantsNCT06772441What this trial is testingArtificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)Who this might be right forProstate Cancer German Oncology Center, Cyprus 30
Not applicableEnded earlyNCT01717677What this trial is testingEvaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" RiskWho this might be right forProstate Cancer Association of Urologic Oncology (AUO) 457
Not applicableActive Not RecruitingNCT01617161What this trial is testingProton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Massachusetts General Hospital 454
Testing effectiveness (Phase 2)WithdrawnNCT04569461What this trial is testingTrimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)Who this might be right forProstate Cancer Duke University
Not applicableActive Not RecruitingNCT01352429What this trial is testingMild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate CancerWho this might be right forProstate Adenocarcinoma Abramson Cancer Center at Penn Medicine 303
Not applicableActive Not RecruitingNCT00890006What this trial is testingAdvanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)Who this might be right forLow or Intermediate Risk Prostate Cancer University Health Network, Toronto 99
Not applicableLooking for participantsNCT06117059What this trial is testingThe PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image GuidanceWho this might be right forLocalized Prostate CancerLow Risk Prostate CancerIntermediate Risk Prostate Cancer NHS Lothian 100
Not applicableStudy completedNCT02342626What this trial is testingDevel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate CancerWho this might be right forAdenocarcinoma of Prostate University of Rochester 140
Not applicableStudy completedNCT01664130What this trial is testingHigh-Dose Stereotactic Radiation for Prostate CancerWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more Case Comprehensive Cancer Center 35
Not applicableEnded earlyNCT02454517What this trial is testingDiet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7 Fred Hutchinson Cancer Center 117
Not applicableStudy completedNCT02104362What this trial is testingSingle Fraction Early Prostate Irradiation (SiFEPI)Who this might be right forProstate Cancer Centre Antoine Lacassagne 35
Large-scale testing (Phase 3)Study completedNCT00002723What this trial is testingLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 390
Not applicableWithdrawnNCT04399824What this trial is testingFocal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04984343What this trial is testingRandomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate CancerWho this might be right forProstate Cancer Weill Medical College of Cornell University 33
Not applicableUnknownNCT04100811What this trial is testingIdentification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ PlatformWho this might be right forProstate Cancer miR Scientific LLC 2,019
Not applicableActive Not RecruitingNCT02339701What this trial is testingStereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate CancerWho this might be right forProstate Cancer Chinese University of Hong Kong 68
Not applicableEnded earlyNCT05826470What this trial is testingInvestigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound ImagingWho this might be right forProstate CancerLow-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Genesis Research LLC 4